Loading...
A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease
BACKGROUND: Platelet inhibition is important for patients with coronary artery disease. When dual antiplatelet therapy (DAPT) is required, a P2Y(12)-antagonist is usually recommended in addition to standard aspirin therapy. The most used P2Y(12)-antagonists are clopidogrel, prasugrel and ticagrelor....
Na minha lista:
| Udgivet i: | Thromb J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558673/ https://ncbi.nlm.nih.gov/pubmed/31198410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-019-0197-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|